Updated 2026-07-27 · NCT07184502See eligibility →
Sponsor
Clinical trials sponsored by Beijing QL Biopharmaceutical Co.,Ltd
Active studies whose public registry record names Beijing QL Biopharmaceutical Co.,Ltd as lead sponsor.
6active studies
3recruiting now
2countries represented
45largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 1
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
Updated 2026-06-22 · NCT07550816See eligibility →
Updated 2026-04-20 · NCT07443059See eligibility →
Updated 2026-07-13 · NCT07697846See eligibility →
Active, not recruitingPhase 3
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Updated 2026-08-03 · NCT07230119See eligibility →
Active, not recruitingPhase 2
Efficacy and Safety of ZT006 in Overweight and Obese Participants
Updated 2026-06-12 · NCT07230132See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.